Peripheral Blood Hematopoietic Cell Transplantation (HCT) + Total body irradiation (TBI) + Cyclophosphamide + Busulfan + FLUDARABINE + FILGRASTIM + Mycophenolate Mofetil Hydrochloride + Sirolimus for graft vs host disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Jan 2017: Trial registered, NCT03018223
  2. 31 Jan 2017: Trial started, NCT03018223

The trials

NCT03018223: Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

State
Completed
Phase
Phase 1
People
32 taking part
Started
31 Jan 2017
Primary completion
15 Dec 2018
Arms
Conditioning/HCT/GVHD Prophylaxis
Results
Posted on the registry
  1. 11 Jan 2017: Trial registered
  2. 31 Jan 2017: Trial started
  3. 21 Jan 2020: Trial results posted
  4. 18 Mar 2021: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.